Release Date: 29/02/12 14:58 Summary: Suspension from Official Quotation close 29/02/12 Price Sensitive: Yes Download Document 21.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%